These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20350264)

  • 1. What is the optimal therapy for Crohn's disease: step-up or top-down?
    Lin MV; Blonski W; Lichtenstein GR
    Expert Rev Gastroenterol Hepatol; 2010 Apr; 4(2):167-80. PubMed ID: 20350264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab in Crohn's disease: early and long-term treatment.
    Armuzzi A; De Pascalis B; Fedeli P; De Vincentis F; Gasbarrini A
    Dig Liver Dis; 2008 Jul; 40 Suppl 2():S271-9. PubMed ID: 18599000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical perspectives in Crohn's disease. Turning traditional treatment strategies on their heads: current evidence for "step-up" versus "top-down".
    Hanauer SB
    Rev Gastroenterol Disord; 2007; 7 Suppl 2():S17-22. PubMed ID: 17392635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical therapy for Crohn's disease: top-down or step-up?
    Baert F; Caprilli R; Angelucci E
    Dig Dis; 2007; 25(3):260-6. PubMed ID: 17827952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.
    Vermeire S; van Assche G; Rutgeerts P
    Aliment Pharmacol Ther; 2007 Jan; 25(1):3-12. PubMed ID: 17229216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological therapies in inflammatory bowel disease: top-down or bottom-up?
    Oldenburg B; Hommes D
    Curr Opin Gastroenterol; 2007 Jul; 23(4):395-9. PubMed ID: 17545775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infliximab use in luminal Crohn's disease.
    Richter JA; Bickston SJ
    Gastroenterol Clin North Am; 2006 Dec; 35(4):775-93. PubMed ID: 17129813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.
    Baert F; Moortgat L; Van Assche G; Caenepeel P; Vergauwe P; De Vos M; Stokkers P; Hommes D; Rutgeerts P; Vermeire S; D'Haens G; ;
    Gastroenterology; 2010 Feb; 138(2):463-8; quiz e10-1. PubMed ID: 19818785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of inflammatory bowel disease in adults.
    Katz JA
    J Dig Dis; 2007 May; 8(2):65-71. PubMed ID: 17532817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab therapy in children with Crohn's disease: a one-year evaluation of efficacy comparing 'top-down' and 'step-up' strategies.
    Kim MJ; Lee JS; Lee JH; Kim JY; Choe YH
    Acta Paediatr; 2011 Mar; 100(3):451-5. PubMed ID: 20626362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's disease.
    Berni Canani R; Terrin G; Borrelli O; Romano MT; Manguso F; Coruzzo A; D'Armiento F; Romeo EF; Cucchiara S
    Dig Liver Dis; 2006 Jun; 38(6):381-7. PubMed ID: 16301010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crohn's disease: current treatment options.
    Akobeng AK
    Arch Dis Child; 2008 Sep; 93(9):787-92. PubMed ID: 18456695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroid-sparing treatments in patients with Crohn's disease.
    Plevy SE
    Am J Gastroenterol; 2002 Jul; 97(7):1607-17. PubMed ID: 12135008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children.
    Hyams J; Crandall W; Kugathasan S; Griffiths A; Olson A; Johanns J; Liu G; Travers S; Heuschkel R; Markowitz J; Cohen S; Winter H; Veereman-Wauters G; Ferry G; Baldassano R;
    Gastroenterology; 2007 Mar; 132(3):863-73; quiz 1165-6. PubMed ID: 17324398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 5-year prospective observational study of the outcomes of international treatment guidelines for Crohn's disease.
    Cullen G; Keegan D; Mulcahy HE; O'Donoghue DP
    Clin Gastroenterol Hepatol; 2009 Mar; 7(3):323-8; quiz 252. PubMed ID: 19174193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of Crohn's disease following corticosteroid-induced remission.
    Papi C; Festa V; Leandro G; Moretti A; Tanga M; Koch M; Capurso L
    Am J Gastroenterol; 2007 Apr; 102(4):814-9. PubMed ID: 17222316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are we ready for top-down therapy for inflammatory bowel diseases: con.
    Herfarth H
    Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):249-55. PubMed ID: 19072417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroids in Crohn's disease.
    Yang YX; Lichtenstein GR
    Am J Gastroenterol; 2002 Apr; 97(4):803-23. PubMed ID: 12003413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to improve the safety of biologic therapy in Crohn's disease.
    Ferkolj I
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():67-70. PubMed ID: 20388947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of chronic inflammatory bowel diseases].
    Lémann M
    Bull Acad Natl Med; 2007 Jun; 191(6):1125-41; discussion 1141. PubMed ID: 18402168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.